Danielle Tullman-Ercek

Dr. Danielle Tullman-Ercek

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2018 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
LBLisa Ann Burdette
Lisa Ann Burdette
SLSamuel Alexander Leach
Samuel Alexander Leach
HWHan Teng Wong
Han Teng Wong
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek
Gram-negative bacteria are attractive hosts for recombinant protein production because they are fast growing, easy to manipulate, and genetically stable in large cultures. However, the utility of these microbes would expand if they also could secrete the product at commercial scales. Secretion of biotechnologically relevant proteins into the extracellular medium increases product purity from cell culture, decreases downstream processing requirements, and reduces overall cost. Thus, researchers are devoting significant attention to engineering Gram-negative bacteria to secrete recombinant proteins to the extracellular medium. Secretion from these bacteria operates through highly specialized systems, which are able to translocate proteins from the cytosol to the extracellular medium in either one or two steps. Building on past successes, researchers continue to increase the secretion efficiency and titer through these systems in an effort to make them viable for industrial production. Efforts include modifying the secretion tags required for recombinant protein secretion, developing methods to screen or select rapidly for clones with higher titer or efficiency, and improving reliability and robustness of high titer secretion through genetic manipulations. An additional focus is the expression of secretion machineries from pathogenic bacteria in the “workhorse” of biotechnology, Escherichia coli, to reduce handling of pathogenic strains. This review will cover recent advances toward the development of high-expressing, high-secreting Gram-negative production strains.

21 June 2017 in ACS Synthetic Biology
Verified
Journal Article
Closed access
MLMarilyn F. Slininger Lee
Marilyn F. Slininger Lee
CJChristopher M. Jakobson
Christopher M. Jakobson
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek

10 September 2022 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
BIBon Ikwuagwu
Bon Ikwuagwu
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek

5 May 2017 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
CJChristopher M Jakobson
Christopher M Jakobson
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek
MSMarilyn F Slininger
Marilyn F Slininger
NMNiall Mangan
Niall Mangan
The spatial organization of metabolism is common to all domains of life. Enteric and other bacteria use subcellular organelles known as bacterial microcompartments to spatially organize the metabolism of pathogenicity-relevant carbon sources, such as 1,2-propanediol. The organelles are thought to sequester a private cofactor pool, minimize the effects of toxic intermediates, and enhance flux through the encapsulated metabolic pathways. We develop a mathematical model of the function of the 1,2-propanediol utilization microcompartment of Salmonella enterica and use it to analyze the function of the microcompartment organelles in detail. Our model makes accurate estimates of doubling times based on an optimized compartment shell permeability determined by maximizing metabolic flux in the model. The compartments function primarily to decouple cytosolic intermediate concentrations from the concentrations in the microcompartment, allowing significant enhancement in pathway flux by the generation of large concentration gradients across the microcompartment shell. We find that selective permeability of the microcompartment shell is not absolutely necessary, but is often beneficial in establishing this intermediate-trapping function. Our findings also implicate active transport of the 1,2-propanediol substrate under conditions of low external substrate concentration, and we present a mathematical bound, in terms of external 1,2-propanediol substrate concentration and diffusive rates, on when active transport of the substrate is advantageous. By allowing us to predict experimentally inaccessible aspects of microcompartment function, such as intra-microcompartment metabolite concentrations, our model presents avenues for future research and underscores the importance of carefully considering changes in external metabolite concentrations and other conditions during batch cultures. Our results also suggest that the encapsulation of heterologous pathways in bacterial microcompartments might yield significant benefits for pathway flux, as well as for toxicity mitigation. Many bacterial species, such as Salmonella enterica (responsible for over 1 million illnesses per year in the United States) and Yersinia pestis (the causative agent of bubonic plague), have a suite of unique metabolic capabilities allowing them to proliferate in the hostile environment of the host gut. Bacterial microcompartments are the subcellular organelles that contain the enzymes responsible for these special metabolic pathways. In this study, we use a mathematical model to explore the possible reasons why Salmonella enclose the 1,2-propanediol utilization metabolic pathway within these sophisticated organelle structures. Using our model, we can examine experimentally inaccessible aspects of the system and make predictions to be tested in future experiments. The metabolic benefits that bacteria gain from the microcompartment system may also prove helpful in enhancing bacterial production of fuels, pharmaceuticals, and specialty chemicals.

11 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
EHEmily C. Hartman
Emily C. Hartman
CJChristopher M. Jakobson
Christopher M. Jakobson
AFAndrew H. Favor
Andrew H. Favor
MLMarco J. Lobba
Marco J. Lobba
EÁEster Álvarez-Benedicto
Ester Álvarez-Benedicto
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek
Self-assembling proteins are critical to biological systems and industrial technologies, but predicting how mutations affect self-assembly remains a significant challenge. Here, we report a technique, termed SyMAPS (Systematic Mutation and Assembled Particle Selection), that can be used to characterize the assembly competency of all single amino acid variants of a self-assembling viral structural protein. SyMAPS studies on the MS2 bacteriophage coat protein revealed a high-resolution fitness landscape that challenges some conventional assumptions of protein engineering. An additional round of selection identified a previously unknown variant (CP[T71H]) that is stable at neutral pH but less tolerant to acidic conditions than the wild-type coat protein. The capsids formed by this variant could be more amenable to disassembly in late endosomes or early lysosomes—a feature that is advantageous for delivery applications. In addition to providing a mutability blueprint for virus-like particles, SyMAPS can be readily applied to other self-assembling proteins.

1 October 2021 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
NKNolan W Kennedy
Nolan W Kennedy
CMCarolyn E Mills
Carolyn E Mills
TNTaylor M Nichols
Taylor M Nichols
CACharlotte H Abrahamson
Charlotte H Abrahamson
DTDanielle Tullman-Ercek
Danielle Tullman-Ercek